Detalhe da pesquisa
1.
Hypothyroidism in Young Children Following Exposure to Iodinated Contrast Media: An Observational Study and a Review of the Literature.
Pediatr Endocrinol Rev
; 16(2): 256-265, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30556658
2.
Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study.
Eur Radiol
; 27(1): 286-295, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26960538
3.
Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study.
Pediatr Radiol
; 46(9): 1317-23, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27041276
4.
Safety and tolerability of iopromide intravascular use: a pooled analysis of three non-interventional studies in 132,012 patients.
Acta Radiol
; 55(6): 707-14, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24043880
5.
Relationship of Dose and Signal Enhancement Properties of Gadoquatrane, a New Tetrameric, Macrocyclic Gadolinium-Based Contrast Agent, Compared With Gadobutrol: A Randomized Crossover Study in Healthy Adults.
Invest Radiol
; 2024 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38904771
6.
Safety and diagnostic image quality of iopromide: results of a large non-interventional observational study of European and Asian patients (IMAGE).
Acta Radiol
; 53(2): 179-86, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22184683
7.
Developments in X-Ray Contrast Media and the Potential Impact on Computed Tomography.
Invest Radiol
; 55(9): 592-597, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32701620
8.
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States.
Invest Radiol
; 54(5): 296-301, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30562272
9.
Safety of gadopentetate dimeglumine after 120 million administrations over 25 years of clinical use.
Magn Reson Med Sci
; 12(4): 297-304, 2013 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-24172794
10.
Evaluation of the effect of two gadolinium-containing contrast-enhancing agents, gadobutrol and gadoxetate disodium, on colorimetric calcium determinations in serum and plasma.
Invest Radiol
; 46(6): 366-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21285889
11.
Prevalence of acute adverse reactions to gadobutrol--a highly concentrated macrocyclic gadolinium chelate: review of 14,299 patients from observational trials.
Eur J Radiol
; 74(3): e186-92, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19574008